The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive analysis of tumor mutational load, genomic alterations, and PD-L1 status in gastrointestinal cancers using a multiplatform molecular profiling tool.
 
Giselle Alexandra Suero-Abreu
No Relationships to Disclose
 
Miguel Gonzalez Velez
No Relationships to Disclose
 
Marshall McKenna
No Relationships to Disclose
 
Narjust Duma
No Relationships to Disclose
 
Sejal Kothadia
No Relationships to Disclose
 
Shalini R Krishnasamy
No Relationships to Disclose
 
Janice Liu
No Relationships to Disclose
 
Ning Dong
No Relationships to Disclose
 
Umar Sharif Khawaja
No Relationships to Disclose
 
Daniel Pievsky
No Relationships to Disclose
 
Tracy Ann Proverbs-Singh
No Relationships to Disclose
 
Martin Gutierrez
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Bayer; Karyopharm Therapeutics; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Foundation One Inc; Merck
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Esanex (Inst); Gilead Sciences (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Rexahn Pharmaceuticals (Inst); TG Therapeutics (Inst)